Skip to main content
. 2024 Oct 19;30:e945832. doi: 10.12659/MSM.945832

Table 1.

Baseline clinical and laboratory characteristics according to ICAT.

Variable All patients (n=171) Low TB (n=57) High TB (n=114) P value
Age, years 59.9±10.8 59.5±10.8 60.2±10.8 0.703
Sex, male % 42.1 43.5 49.5 0.105
Diabetes, % 18.3 10.7 22.1 0.052
Hypertension, % 38.6 33.3 41.6 0.203
Smoking, % 21.6 19.3 22.8 0.376
Dyslipidemia, % 41.9 41.8 42.0 0.560
Previous history of CAD, % 18.3 15.8 16.7 0.536
Family history of CAD 32.4 15.8 16.7 0.884
SBP, mmHg 137±18 141±120 135±11 0.046
CRP, mg/dL 1 (0.1–2.80) 0.80 (0.10–2.8) 1.11 (0.3–2.8) 0.037
Uric acid mg/dL 5.2 (3.4–7.2) 4.9 (3.4–5.6) 5.4 (3.5–7.2) <0.001
Albumin, g/dL 3.2 (2.7–4.4) 3.3 (2.1–4.4) 3.1 (2.1–4.4) 0.243
UAR 1.61 (0.77–3) 1.48 (0.77–2.57) 1.78 (0.82–3) <0.001
Hemoglobin, g/dL 13.4±2 14.8±1.6 14.5±1.7 0.430
WBC count×103/μL 7.9±2.5 8.3±2.6 7.8±2.4 0.198
Baseline troponin I, Ng/L* 555 (55–7000) 480 (55–4000) 605 (100–7000) 0.003
LDL cholesterol, mg/dL 148±14 150±15 146±14 0.176
HDL cholesterol, mg/dL 30±11 30±13 30±10 0.935
Triglyceride, mg/dL 196±70 205±71 192±69 0.702
GFR 61±17 60.8±18 63±17 0.460
BMI 24 (16–36) 23 (16–31) 24 (16.9–36) 0.206
LVEF, % 46.2±9.2 50.5±6.3 42.3±6.7 <0.001
No-reflow % 4.1 1.8 5.3 0.275
PWC time, min 315±87 265.7±127 341±96 <0.001
Previous medications, %
Aspirin 20.5 19.3 21.1 0.479
Statin 17.5 19.3 16.7 0.674
ACE inhibitors/ARB 24.0 21.1 25.4 0.574
β-blocker 12.9 14.0 12.3 0.810

ACE – angiotensin converting enzyme; ARB – angiotensin receptor blocker; BMI – body mass index; CAD – coronary artery disease; CCB – calcium channel blocker; CRP – C-reactive protein; LVEF – left ventricular ejection fraction; GFR – glomerular filtration rate; HDL – high-density lipoprotein; ICAT – intracoronary arterial thrombus; LDL – low-density lipoprotein; PWC – pain to wire crossing time; SBP – systolic blood pressure; UA – uric acid; UAR – uric acid albumin ratio; WBC – white blood cell.

*

The normal cut-off value of troponin in our laboratory <100 Ng/L.